Last reviewed · How we verify

NCT06877195: RiVEST

Multicenter Randomised Prospective Study for External Support Mesh VEST of Venous Coronary Grafts on the Right Territory

Recruiting now NA Last updated 18 March 2025
What this trial tests

NA trial testing CABG in Ischemic Cardiovascular Disease in 300 participants. Currently enrolling.

Timeline
1 March 2025
Primary endpoint
1 March 2028
1 May 2028

Quick facts

Lead sponsorCardiochirurgia E.H.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment300
Start date1 March 2025
Primary completion1 March 2028
Estimated completion1 May 2028
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Cardiochirurgia E.H. — full company profile →

Who can join

Eligibility, any sex, with Ischemic Cardiovascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicentre randomised prospective study aimed at verifying medium-term patency of venous grafts on the right coronary artery territory, by clinical and/or instrumental follow-up with particular attention to clinically driven re-revascularisation events regarding the site of new lesions (granularly comparing sites already treated with VEST, sites treated with bare vein, sites treated with other conduits, de novo lesions on the native).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CABG

Trials testing the same drug.

Other recruiting trials for Ischemic Cardiovascular Disease

Currently open trials in the same condition.

Other Cardiochirurgia E.H. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06877195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing